Erythromelalgia and livedo reticularis in a patient with essential thrombocythemia, acquired von Willebrand disease, and elevated anti-phospholipid antibodies

Annals of Dermatology

Volumn 24, Issue 2, 2012, Pages 214-217

  Gambichler, Thilo ^a   Matip, Rebecca ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Erythromelalgia; Essential thrombocythemia; Livedo reticularis; Von Willebrand disease

Indexed keywords

EID: 84860641514     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2012.24.2.214     Document Type: Article

References (12)

1. Brière JB. Essential thrombocythemia. Orphanet J Rare Dis 2007;2:3.
2. Tefferi A, Vainchenker W. Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 2011;29:573-582.
3. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 2006;81:159-166. (Pubitemid 43205767)
4. Buggiani G, Krysenka A, Grazzini M, Vašků V, Hercogová J, Lotti T. Paraneoplastic vasculitis and paraneoplastic vascular syndromes. Dermatol Ther 2010;23:597-605.
5. Tarach JS, Nowicka-Tarach BM, Matuszek B, Nowakowski A. Erythromelalgia-a thrombotic complication in chronic myeloproliferative disorders. Med Sci Monit 2000;6:204-208. (Pubitemid 30158266)
6. Bauerschmitz J, Knop J. Cutaneous manifestations of essential thrombocythemia. Erythromelalgia, ischemic acrocyanosis, livedo racemosa. Hautarzt 1995;46:477-480.
7. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 2006;33:2379-2382. (Pubitemid 46075025)
8. Finazzi G. Essential thrombocythemia. Cancer Treat Res 2008;142:51-68.
9. Wieczorek I, MacGregor IR, Ludlam CA. Low proteins C and S and activation of fibrinolysis in treated essential thrombocythemia. Am J Hematol 1995;49:277-281.
10. Harrison CN, Donohoe S, Carr P, Dave M, Mackie I, Machin SJ. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Thromb Haemost 2002;87:802-807. (Pubitemid 34516605)
11. Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, et al. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol 1992;65:70-74.
12. Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand disease. Mayo Clin Proc 2002;77:181-187. (Pubitemid 34118895)